Table 4.
Some demographic and clinical data of the patients who entered the PABD programme, classified according to whether adjuvant treatment with EPO was used or not. All data are the mean±standard deviation ( Hb previous haemoglobin before PABD, U blood units, U/pt units per patient, auto autologous blood, allo allogeneic blood)
| EPO | No EPO | P | |
|---|---|---|---|
| (124) | (556) | ||
| Age (years) | 37±20 | 44±16 | <0.05 |
| Weight (kg) | 62±15 | 71±17 | <0.05 |
| Hb previous (g/L) | 128±11 | 145±13 | <0.05 |
| Requested units (U/pt) | 2.77±0.64 | 2.61±0.58 | <0.05 |
| Donated units (U/pt) | 2.49±0.97 | 2.38±0.76 | NS |
| Transfusion auto (U/pt) | 1.72±1.24 | 1.47±1.16 | NS |
| Transfusion allo (U/pt) | 0.66±1.38 | 0.50±1.20 | NS |
| Total transfusion (U/pt) | 2.38±2.13 | 1.96±1.85 | NS |